Stimulation of FasL induces production of proinflammatory mediators through activation of mitogen-activated protein kinases and nuclear factor-κB in THP-1 cells

Inflammation

Volumn 35, Issue 1, 2012, Pages 1-10

  Lee, Sang Min ^a   Kim, Eun Ju ^a   Suk, Kyoungho ^b   Lee, Won Ha ^a  

^a Kyungpook National University   (South Korea)

^b Kyungpook National University School of Medicine   (South Korea)

Author keywords

FasL; Inflammation; Macrophage; Signal transduction; TNFSF

Indexed keywords

AUTACOID; FAS LIGAND; GELATINASE B; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 8; MITOGEN ACTIVATED PROTEIN KINASE; MITOGEN ACTIVATED PROTEIN KINASE P38; SMALL INTERFERING RNA; STRESS ACTIVATED PROTEIN KINASE; TUMOR NECROSIS FACTOR ALPHA;

ARTICLE; BINDING ASSAY; CELL PHAGOCYTOSIS; CELL STIMULATION; CONTROLLED STUDY; CYTOKINE PRODUCTION; CYTOKINE RESPONSE; ENZYME ACTIVATION; ENZYME LINKED IMMUNOSORBENT ASSAY; HUMAN; HUMAN CELL; IMMUNOPATHOGENESIS; INTRACELLULAR SIGNALING; MACROPHAGE ACTIVATION; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN INDUCTION; PROTEIN PROTEIN INTERACTION; TRANSCRIPTION INITIATION; TRANSCRIPTION REGULATION; UPREGULATION;

ANTIBODIES, MONOCLONAL; ANTIGENS, CD95; ANTIGENS, SURFACE; CELL LINE, TUMOR; EXTRACELLULAR SIGNAL-REGULATED MAP KINASES; FAS LIGAND PROTEIN; HUMANS; INTERLEUKIN-8; JNK MITOGEN-ACTIVATED PROTEIN KINASES; MACROPHAGE ACTIVATION; MACROPHAGES; MAP KINASE SIGNALING SYSTEM; MATRIX METALLOPROTEINASE 9; MEMBRANE GLYCOPROTEINS; NF-KAPPA B; P38 MITOGEN-ACTIVATED PROTEIN KINASES; RECEPTORS, FC; RECOMBINANT FUSION PROTEINS; RNA INTERFERENCE; RNA, SMALL INTERFERING; TUMOR NECROSIS FACTOR-ALPHA;

EID: 84856370909     PISSN: 03603997     EISSN: 15732576     Source Type: Journal    
DOI: 10.1007/s10753-010-9283-3     Document Type: Article

References (42)

1. Chen, N.J., M.W. Huang, and S.L. Hsieh. 2001. Enhanced secretion of IFN-gamma by activated Th1 cells occurs via reverse signaling through TNF-related activation-induced cytokine. Journal of Immunology 166: 270-276.
2. van Essen, D., H. Kikutani, and D. Gray. 1995. CD40 ligandtransduced co-stimulation of T cells in the development of helper function. Nature 378: 620-623.
3. Cerutti, A., A. Schaffer, R.G. Goodwin, S. Shah, H. Zan, S. Ely, and P. Casali. 2000. Engagement of CD153 (CD30 ligand) by CD30+ T cells inhibits class switch DNA recombination and antibody production in human IgD+IgM+B cells. Journal of Immunology 165: 786-794. (Pubitemid 30484745)
4. Zhang, J., T.W. Salcedo, X. Wan, S. Ullrich, B. Hu, T. Gregorio, P. Feng, S. Qi, H. Chen, Y.H. Cho, Y. Li, P.A. Moore, and J. Wu. 2001. Modulation of T-cell responses to alloantigens by TR6/DcR3. Journal of Clinical Investigation 107: 1459-1468. (Pubitemid 32522040)
5. Chou, A.H., H.F. Tsai, L.L. Lin, S.L. Hsieh, P.I. Hsu, and P.N. Hsu. 2001. Enhanced proliferation and increased IFN-gamma production in T cells by signal transduced through TNF-related apoptosis-inducing ligand. Journal of Immunology 167: 1347-1352.
6. Suzuki, I., and P.J. Fink. 2000. The dual functions of fas ligand in the regulation of peripheral CD8+ and CD4+ T cells. Proceedings of the National Academy of Sciences of the United States of America 97: 1707-1712. (Pubitemid 30118507)
7. Bae, E.M., W.J. Kim, K. Suk, Y.M. Kang, J.E. Park, W.Y. Kim, E. M. Choi, B.K. Choi, B.S. Kwon, and W.H. Lee. 2008. Reverse signaling initiated from GITRL induces NF-kappaB activation through ERK in the inflammatory activation of macrophages. Molecular Immunology 45: 523-533. (Pubitemid 47332628)
8. Jeon, S.T., W.J. Kim, S.M. Lee, M.Y. Lee, S.B. Park, S.H. Lee, I.S. Kim, K. Suk, B.K. Choi, E.M. Choi, B.S. Kwon, and W.H. Lee. 2010. Reverse signaling through BAFF differentially regulates the expression of inflammatory mediators and cytoskeletal movements in THP-1 cells. Immunology and Cell Biology 88: 148-156.
9. Lee, S.M., S.T. Jeon, W.J. Kim, K. Suk, and W.H. Lee. 2010. Macrophages express membrane bound form of APRIL that can generate immunomodulatory signals. Immunology 131: 350-356.
10. Lettau, M., M. Paulsen, D. Kabelitz, and O. Janssen. 2009. FasL expression and reverse signalling. Results and Problems in Cell Differentiation 49: 49-61.
11. Krammer, P.H., R. Arnold, and I.N. Lavrik. 2007. Life and death in peripheral T cells. Nature Reviews. Immunology 7: 532-542. (Pubitemid 46987784)
12. Brunner, T., C. Wasem, R. Torgler, I. Cima, S. Jakob, and N. Corazza. 2003. Fas (CD95/Apo-1) ligand regulation in T cell homeostasis, cell-mediated cytotoxicity and immune pathology. Seminars in Immunology 15: 167-176. (Pubitemid 38155823)
13. Igney, F.H., and P.H. Krammer. 2005. Tumor counterattack: fact or fiction? Cancer Immunology, Immunotherapy 54: 1127-1136. (Pubitemid 41396816)
14. Niederkorn, J.Y. 2006. See no evil, hear no evil, do no evil: the lessons of immune privilege. Nature Immunology 7: 354-359.
15. Suzuki, I., and P.J. Fink. 1998. Maximal proliferation of cytotoxic T lymphocytes requires reverse signaling through Fas ligand. The Journal of Experimental Medicine 187: 123-128. (Pubitemid 28044827)
16. Suzuki, I., S. Martin, T.E. Boursalian, C. Beers, and P.J. Fink. 2000. Fas ligand costimulates the in vivo proliferation of CD8+ T cells. Journal of Immunology 165: 5537-5543.
17. Desbarats, J., R.C. Duke, and M.K. Newell. 1998. Newly discovered role for Fas ligand in the cell-cycle arrest of CD4+ T cells. Natural Medicines 4: 1377-1382. (Pubitemid 28553459)
18. Sun, M., S. Lee, S. Karray, M. Levi-Strauss, K.T. Ames, and P.J. Fink. 2007. Cutting edge: two distinct motifs within the Fas ligand tail regulate Fas ligand-mediated costimulation. Journal of Immunology 179: 5639-5643.
19. Sun, M., K.T. Ames, I. Suzuki, and P.J. Fink. 2006. The cytoplasmic domain of Fas ligand costimulates TCR signals. Journal of Immunology 177: 1481-1491. (Pubitemid 44092481)
20. Sun, M., and P.J. Fink. 2007. A new class of reverse signaling costimulators belongs to the TNF family. Journal of Immunology 179: 4307-4312.
21. Izawa, K., J. Kitaura, Y. Yamanishi, T. Matsuoka, A. Kaitani, M. Sugiuchi, M. Takahashi, A. Maehara, Y. Enomoto, T. Oki, T. Takai, and T. Kitamura. 2009. An activating and inhibitory signal from an inhibitory receptor LMIR3/CLM-1: LMIR3 augments lipopolysaccharide response through association with FcRgamma in mast cells. Journal of Immunology 183: 925-936.
22. Lee, S.M., Y.P. Nam, K. Suk, and Lee WH. 2010. Immune receptor expressed on myeloid cells 1 (IREM-1) inhibits B cell activation factor (BAFF)-mediated inflammatory regulation of THP-1 cells through modulation of the activities of extracellular regulated kinase (ERK). Clinical & Experimental Immunology 161: 504-511.
23. Xi, H., K.J. Katschke Jr., K.Y. Helmy, P.A. Wark, N. Kljavin, H. Clark, J. Eastham-Anderson, T. Shek, M. Roose-Girma, N. Ghilardi, and M. van Lookeren Campagne. 2010. Negative regulation of autoimmune demyelination by the inhibitory receptor CLM-1. The Journal of Experimental Medicine 207(7-16): S1-S5.
24. Chong, Z.Z., and K. Maiese. 2007. The Src homology 2 domain tyrosine phosphatases SHP-1 and SHP-2: diversified control of cell growth, inflammation, and injury. Histology and Histopathology 22: 1251-1267. (Pubitemid 47470319)
25. Lorenz, U. 2009. SHP-1 and SHP-2 in T cells: two phosphatases functioning at many levels. Immunological Reviews 228: 342-359.
26. Bonny, C., A. Oberson, S. Negri, C. Sauser, and D.F. Schorderet. 2001. Cell-permeable peptide inhibitors of JNK: novel blockers of beta-cell death. Diabetes 50: 77-82. (Pubitemid 32047984)
27. Rosenau, C., D. Emery, B. Kaboord, and M.W. Qoronfleh. 2004. Development of a high-throughput plate-based chemiluminescent transcription factor assay. Journal of Biomolecular Screening 9: 334-342.
28. Lee, W.H., S.H. Kim, Y. Lee, B.B. Lee, B. Kwon, H. Song, B.S. Kwon, and J.E. Park. 2001. Tumor necrosis factor receptor superfamily 14 is involved in atherogenesis by inducing proinflammatory cytokines and matrix metalloproteinases. Arteriosclerosis, Thrombosis, and Vascular Biology 21: 2004-2010. (Pubitemid 34219754)
29. Kim, W.J., and W.H. Lee. 2004. LIGHT is expressed in foam cells and involved in destabilization of atherosclerotic plaques through induction of matrix metalloproteinase-9 and IL-8. Immune Network 4: 116-122.
30. Guha, M., and N. Mackman. 2001. LPS induction of gene expression in human monocytes. Cellular Signalling 13: 85-94. (Pubitemid 32222977)
31. Hu, X., L.C. Moscinski, N.I. Valkov, A.B. Fisher, B.J. Hill, and K. S. Zuckerman. 2000. Prolonged activation of the mitogen-activated protein kinase pathway is required for macrophage-like differentiation of a human myeloid leukemic cell line. Cell Growth & Differentiation 11: 191-200. (Pubitemid 30211008)
32. Requena, P., A. Daddaoua, E. Guadix, A. Zarzuelo, M.D. Suarez, F. Sanchez de Medina, and O. Martinez-Augustin. 2009. Bovine glycomacropeptide induces cytokine production in human monocytes through the stimulation of the MAPK and the NF-kappaB signal transduction pathways. British Journal of Pharmacology 157: 1232-1240.
33. Yang, Y., N. Lu, J. Zhou, Z.N. Chen, and P. Zhu. 2008. Cyclophilin A up-regulates MMP-9 expression and adhesion of monocytes/macrophages via CD147 signalling pathway in rheumatoid arthritis. Rheumatology (Oxford) 47: 1299-1310.
34. Ballif, B.A., A. Shimamura, E. Pae, and J. Blenis. 2001. Disruption of 3-phosphoinositide-dependent kinase 1 (PDK1) signaling by the anti-tumorigenic and anti-proliferative agent N-alpha-tosyl-L-phenylalanyl chloromethyl ketone. The Journal of Biological Chemistry 276: 12466-12475.
35. Han, Y., J.A. Englert, R. Yang, R.L. Delude, and M.P. Fink. 2005. Ethyl pyruvate inhibits nuclear factor-κB-dependent signaling by directly targeting p65. The Journal of Pharmacology and Experimental Therapeutics 312: 1097-1105. (Pubitemid 40293769)
36. Wahl, C., S. Liptay, G. Adler, and R.M. Schmid. 1998. Sulfasalazine: a potent and specific inhibitor of nuclear factor kappa B. Journal of Clinical Investigation 101: 1163-1174. (Pubitemid 28125296)
37. Fenteany, G., and M. Glogauer. 2004. Cytoskeletal remodeling in leukocyte function. Current Opinion in Hematology 11: 15-24. (Pubitemid 38021717)
38. May, R.C., and L.M. Machesky. 2001. Phagocytosis and the actin cytoskeleton. Journal of Cell Science 114: 1061-1077. (Pubitemid 32288521)
39. Alvarez-Errico, D., H. Aguilar, F. Kitzig, T. Brckalo, J. Sayos, and M. Lopez-Botet. 2004. IREM-1 is a novel inhibitory receptor expressed by myeloid cells. European Journal of Immunology 34: 3690-3701. (Pubitemid 40012187)
40. Sui, L., N. Li, Q. Liu, W. Zhang, T. Wan, B. Wang, K. Luo, H. Sun, and X. Cao. 2004. IgSF13, a novel human inhibitory receptor of the immunoglobulin superfamily, is preferentially expressed in dendritic cells and monocytes. Biochemical and Biophysical Research Communications 319: 920-928. (Pubitemid 38739408)
41. Chung, D.H., M.B. Humphrey, M.C. Nakamura, D.G. Ginzinger, W.E. Seaman, and M.R. Daws. 2003. CMRF-35-like molecule-1, a novel mouse myeloid receptor, can inhibit osteoclast formation. Journal of Immunology 171: 6541-6548. (Pubitemid 37532084)
42. Alvarez-Errico, D., J. Sayos, and M. Lopez-Botet. 2007. The IREM-1 (CD300f) inhibitory receptor associates with the p85alpha subunit of phosphoinositide 3-kinase. Journal of Immunology 178: 808-816. (Pubitemid 46095153)